215 related articles for article (PubMed ID: 37559999)
1. Autotaxin production in the human breast cancer tumor microenvironment mitigates tumor progression in early breast cancers.
Benesch MG; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K
Am J Cancer Res; 2023; 13(7):2790-2813. PubMed ID: 37559999
[TBL] [Abstract][Full Text] [Related]
2. Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion.
Benesch MGK; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190226
[TBL] [Abstract][Full Text] [Related]
3. High
Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K
Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
[TBL] [Abstract][Full Text] [Related]
5. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
Brindley DN; Tang X; Meng G; Benesch MGK
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression.
Benesch MGK; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372960
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.
Wu R; Sarkar J; Tokumaru Y; Takabe Y; Oshi M; Asaoka M; Yan L; Ishikawa T; Takabe K
Am J Cancer Res; 2022; 12(2):504-520. PubMed ID: 35261783
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
9. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.
Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN
FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer.
Benesch MGK; Tang X; Brindley DN; Takabe K
World J Oncol; 2024 Feb; 15(1):1-13. PubMed ID: 38274724
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
[TBL] [Abstract][Full Text] [Related]
12. Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs.
Shinde A; Tang X; Singh R; Brindley DN
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201482
[TBL] [Abstract][Full Text] [Related]
13. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
[TBL] [Abstract][Full Text] [Related]
14. Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer.
Konen JM; Rodriguez BL; Wu H; Fradette JJ; Gibson L; Diao L; Wang J; Schmidt S; Wistuba II; Zhang J; Gibbons DL
J Clin Invest; 2023 Sep; 133(17):. PubMed ID: 37655662
[TBL] [Abstract][Full Text] [Related]
15. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
16. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not.
Tang X; Morris AJ; Deken MA; Brindley DN
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296899
[TBL] [Abstract][Full Text] [Related]
18. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.
She S; Zhang Q; Shi J; Yang F; Dai K
Front Oncol; 2022; 12():922945. PubMed ID: 35769713
[TBL] [Abstract][Full Text] [Related]
19. The Expression Regulation and Biological Function of Autotaxin.
Zhang X; Li M; Yin N; Zhang J
Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
[TBL] [Abstract][Full Text] [Related]
20. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8
Matas-Rico E; Frijlink E; van der Haar Àvila I; Menegakis A; van Zon M; Morris AJ; Koster J; Salgado-Polo F; de Kivit S; Lança T; Mazzocca A; Johnson Z; Haanen J; Schumacher TN; Perrakis A; Verbrugge I; van den Berg JH; Borst J; Moolenaar WH
Cell Rep; 2021 Nov; 37(7):110013. PubMed ID: 34788605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
